Holen Sie sich die Stockscreener-App
6.40
1.59%
0.10
Handel nachbörslich:
6.35
-0.05
-0.78%
Schlusskurs vom Vortag:
$6.30
Offen:
$6.35
24-Stunden-Volumen:
10,349
Relative Volume:
0.62
Marktkapitalisierung:
$17.78M
Einnahmen:
$22.03M
Nettoeinkommen (Verlust:
$-19.91M
KGV:
-0.3457
EPS:
-18.5137
Netto-Cashflow:
$-16.84M
1W Leistung:
-9.54%
1M Leistung:
-2.59%
6M Leistung:
+0.88%
1J Leistung:
-61.07%
1-Tages-Spanne:
$6.30
$6.675
1-Wochen-Bereich:
$6.30
$7.17
52-Wochen-Spanne:
$4.14
$17.76
Lifeward Ltd Stock (LFWD) Company Profile
Firmenname
Lifeward Ltd
Sektor
Branche
Telefon
15082511154
Adresse
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.40 | 17.51M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-10 | Eingeleitet | Laidlaw | Buy |
| 2017-04-03 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Eingeleitet | Oppenheimer | Outperform |
| 2016-07-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-05-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Bestätigt | Barclays | Equal Weight |
| 2014-10-07 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Lifeward Ltd Aktie (LFWD) Neueste Nachrichten
Earnings Preview: Lifeward to Report Financial Results Pre-market on May 15 - Moomoo
The credit profile of Lifeward (LFWD) revealed | Q4 2025: EPS Misses ViewsBuy Rating - newser.com
Lifeward Ltd expected to post a loss of $1.25 a shareEarnings Preview - TradingView
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026 - Caledonian Record
Lifeward (LFWD) price target decreased by 37.93% to 4.59 - MSN
LFWD Q1'26 Earnings: EPS estimate is (1.18) USD - TradingView
Study of Lifeward exoskeleton found zero fractures in 97 Germany users - Stock Titan
ReWalk exoskeleton shows near-zero fracture rates over six years, boosting safety confidence for spinal injury mobility. - Pluang
ORMP News | ORAMED PHARMACEUTICALS INC (NASDAQ:ORMP) - ChartMill
Working capital per share of Lifeward Ltd. – MUN:2RW - TradingView
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
7.26M Lifeward shares registered for resale by selling holders (NASDAQ: LFWD) - Stock Titan
Lifeward stock plummets on pricing of $2.6M public offering - MSN
Jeannine Lynch to Exit Lifeward as VP of Strategy and Market Access - TradingView
Lifeward (NASDAQ: LFWD) to end VP Strategy role May 3 - Stock Titan
Moshe H Rozenbaum Net Worth (2026) - GuruFocus
William Mark Sigsbee Net Worth (2026) - GuruFocus
Lifeward (LFWD) director receives 11,485 RSUs vesting over four quarters - Stock Titan
Lifeward Ltd. (LFWD) director submits Form 3 with no insider trades - Stock Titan
Lifeward (LFWD) awards 11,485 RSUs to company director - Stock Titan
Lifeward (LFWD) director Moshe H Rozenbaum files initial Form 3 - Stock Titan
Returns Recap: Can Lifeward Ltd be recession proofPortfolio Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Recap Report: Is Lifeward Ltd a turnaround storyWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug PreEarnings: Is Lifeward Ltd a good stock for dollar cost averaging2026 Reactions & Reliable Volume Spike Alerts - baoquankhu1.vn
Aug Setups: Why is Lifeward Ltd stock going upMarket Trend Report & High Accuracy Trade Alerts - baoquankhu1.vn
Lifeward scoops US$20M after completing Oratech Pharma takeover - Mugglehead Investment Magazine
Sell Signal: Does Lifeward Ltd offer margin of safety2026 Risk Factors & Technical Buy Zone Confirmation - baoquankhu1.vn
Big Picture: Will Lifeward Ltd benefit from government policyForecast Cut & Advanced Technical Signal Analysis - baoquankhu1.vn
S P Trends: Is Lifeward Ltd stock heavily shorted2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
LFWD Earnings History & Surprises | EPS & Revenue Results | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - The Globe and Mail
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - Investing.com South Africa
Lifeward regains Nasdaq compliance after audit committee appointments - investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - Stock Titan
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - Stock Titan
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - Stock Titan
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - Stock Titan
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
Finanzdaten der Lifeward Ltd-Aktie (LFWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):